Intellia Therapeutics annual gross margin
2018
2019
2020
2021
Intellia Therapeutics Gross Margin Growth & History (NTLA)
Intellia Therapeutics's gross margin was 100.00% for fiscal 2021.
View full Intellia Therapeutics company overviewIntellia Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 100.00% | 0.00 pp |
| 2020 | 2020-12-31 | 100.00% | 0.00 pp |
| 2019 | 2019-12-31 | 100.00% | 0.00 pp |
| 2018 | 2018-12-31 | 100.00% | — |
Intellia Therapeutics quarterly gross margin
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2019 | 2019-12-31 | 100.00% | — |
| Q3 2019 | 2019-09-30 | 100.00% | 0.00 pp |
| Q2 2019 | 2019-06-30 | 100.00% | — |
| Q1 2019 | 2019-03-31 | 100.00% | — |
| Q3 2018 | 2018-09-30 | 100.00% | — |
Intellia Therapeutics gross margin trends
Between the periods ended 2018-12-31 and 2021-12-31, Intellia Therapeutics's gross margin increased from 100.00% to 100.00%, a change of 0.00 percentage points. The latest reported quarter, Q4 2019, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intellia Therapeutics source filings ↗